Multiple micronutrient powders are a public health intervention and product backed by 20 years of research. This blog briefly summarizes some important developments in the world of multiple micronutrients. In late 2018, the team at the Hospital for Sick Kids Canada submitted MNPs to the World Health Organization for consideration on its Essential Medicines List. Maternova’s Multiple Micronutrient Powder 5 component (MNP5) counters anaemia and vitamin and mineral deficiencies. The 20 dose sachets are eco-friendly, more efficient and have lower cost per saving. This specific type of micronutrient is for children 6 months to 12 years of age. The product itself is a fine, off white, odorless powder, which has little impact on the taste, smell or color of the food when mixed. Under cool and dry storage conditions, the shelf life expectation of MNP5 is 2 years. Under tropical conditions, the micronutrient has a minimum one year shelf life expectation. While Sprinkles is the original brand name, micronutrients are called a variety of names across different countries. MNPs are branded Chispitas in countries like Peru and Bolivia. According to UNICEF’s “Micronutrient Powders: Current Global Program Implementation Status and Challenges,” by 2011, 22 countries were using MNPs. By 2013, it was 43 countries. Every year, 20 million children across 65 countries are already receiving Sprinkles. 

According to WHO, “MNP are an efficacious intervention for reducing iron deficiency anaemia and filling important nutrient gaps in children 6-23 months of age.” WHO also has two different sets of guidelines when it comes to micronutrients; one for infants 6 months to 23 months of age, and another for ages 24 months to 12 years. For the 6 to 23 month age group, WHO states, “In conclusion, an MNP formulation including a dose of 12.5 mg of elemental iron (as ferrous fumarate), 5 mg of zinc and 300 μg of vitamin A is effective and the addition of other vitamins and minerals could be considered within the recommended daily values for this age group.” For the older age group, “Based on the body of evidence, it was concluded that the use of iron-containing MNP for point-of-use fortification of foods can help control anemia and iron deficiency in preschool and school age children (i.e. 2-12 years of age). In conclusion, an MNP formulation including a dose of 12.5 mg of elemental iron (as ferrous fumarate), 5 mg of zinc and 300 μg of vitamin A is effective and the addition of other vitamins and minerals could be considered within the recommended daily values for this age group.” 

Part of the barrier in expanding the use of multiple micronutrient powders is knowledge of the product. There is also the issue of finding access to small to medium sized quantities. Additional problems that may arise are lack of trust in a product and shipping costs. Maternova has set about to tackle these hurdles one by one. 

 

 

UN Photo/Rick Bajornas

Secretary-General Visits Dominica in Wake of Hurricane Maria

Secretary-General António Guterres and his delegation visited Salybia, Dominica, to survey the local relief effort. They met with local authorities and community members during a multi-sector distribution effort, in the wake of the devastation caused by the passage of Hurricane Maria in September.

Children in Salybia.

08 October 2017

Salybia, Dominica

Photo # 737437



Leave a comment

Comments will be approved before showing up.


Also in The Maternova Blog

Benefits of intravenous iron to treat anemia in pregnancy
Benefits of intravenous iron to treat anemia in pregnancy

March 19, 2024 5 min read

Read More
A Point of Care Bilirubinometer Using Blood: BiliDx
A Point of Care Bilirubinometer Using Blood: BiliDx

January 16, 2024 2 min read

The BiliDx is a novel system for diagnosing jaundice.  The device uniquely meets the Target Product Profile (TPP) developed as part of the NEST 360 initiative in that it allows blood-based testing at the bedside.   This initiative is part of an emerging global consensus in the Every Newborn Action Plan that countries need functional WHO level-2 inpatient units to care for "small and sick newborns." 
Read More
NASG as a life-saving medical device to stabilize women with postpartum hemorrhage
Clinical Indications for Applying (and Removing) the NASG: Rule of 20

January 15, 2024 2 min read

The garment must be removed upon reaching hemodynamic stability for at least two hours, where it is evident:

  • Blood loss less than 50 mL/hour
  • Pulse less than 100 beats per minute
Read More